RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke

Himiko Tokami, Tetsuro Ago, Hiroshi Sugimori, Junya Kuroda, Hideto Awano, Kazuo Suzuki, Yutaka Kiyohara, Masahiro Kamouchi, Takanari Kitazono

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) is a well-known pro-inflammatory chemokine and its role in ischemic stroke remains controversial. We examined the significance of RANTES in ischemic stroke and aimed to elucidate the direct effect of RANTES on neurons. Plasma concentrations of major C-C chemokines, including RANTES, and neurotrophic factors were examined in 171 ischemic stroke patients and age- and gender- matched healthy subjects. Plasma concentrations of RANTES at day 0 after onset were significantly elevated in stroke patients, compared with controls, and were highly correlated with those of BDNF, EGF, and VEGF. In a mouse middle cerebral artery occlusion model (MCAO), plasma RANTES was significantly elevated and the expression of RANTES was markedly upregulated in neurons particularly in peri-infarct areas. The expression of CCR3 and CCR5, receptors for RANTES, was also induced in neurons, while another receptor, CCR1, was observed in vascular cells, in peri-infarct areas after MCAO. We examined the effects of RANTES on differentiated PC12 cells, a model of neuronal cells. Treatment with RANTES induced the activation of Akt and Erk1/2, and attenuated the cleavage of caspase-3 in the cells. RANTES increased the expression of BDNF, EGF, and VEGF in the cells. Moreover, RANTES maintained the number of cells under serum free conditions. The RANTES-mediated upregulation of neurotrophic factors and cell survival were significantly attenuated by the inhibition of Akt or Erk1/2. Taken together, RANTES is an interesting chemokine that is produced from neurons after ischemic stroke and has the potential to protect neurons directly or indirectly through the production of neurotrophic factors in peri-infarct areas.

Original languageEnglish
Pages (from-to)122-132
Number of pages11
JournalBrain Research
Volume1517
DOIs
Publication statusPublished - Jun 23 2013

Fingerprint

Stroke
T-Lymphocytes
Nerve Growth Factors
Neurons
Middle Cerebral Artery Infarction
Brain-Derived Neurotrophic Factor
Chemokines
Epidermal Growth Factor
Vascular Endothelial Growth Factor A
CCR1 Receptors
CCR3 Receptors
CCR5 Receptors
CC Chemokines
PC12 Cells
Caspase 3
Blood Vessels
Cell Survival
Healthy Volunteers
Up-Regulation
Cell Count

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke. / Tokami, Himiko; Ago, Tetsuro; Sugimori, Hiroshi; Kuroda, Junya; Awano, Hideto; Suzuki, Kazuo; Kiyohara, Yutaka; Kamouchi, Masahiro; Kitazono, Takanari.

In: Brain Research, Vol. 1517, 23.06.2013, p. 122-132.

Research output: Contribution to journalArticle

Tokami, Himiko ; Ago, Tetsuro ; Sugimori, Hiroshi ; Kuroda, Junya ; Awano, Hideto ; Suzuki, Kazuo ; Kiyohara, Yutaka ; Kamouchi, Masahiro ; Kitazono, Takanari. / RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke. In: Brain Research. 2013 ; Vol. 1517. pp. 122-132.
@article{b1cc105509534af0845e9222dd79bedc,
title = "RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke",
abstract = "Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) is a well-known pro-inflammatory chemokine and its role in ischemic stroke remains controversial. We examined the significance of RANTES in ischemic stroke and aimed to elucidate the direct effect of RANTES on neurons. Plasma concentrations of major C-C chemokines, including RANTES, and neurotrophic factors were examined in 171 ischemic stroke patients and age- and gender- matched healthy subjects. Plasma concentrations of RANTES at day 0 after onset were significantly elevated in stroke patients, compared with controls, and were highly correlated with those of BDNF, EGF, and VEGF. In a mouse middle cerebral artery occlusion model (MCAO), plasma RANTES was significantly elevated and the expression of RANTES was markedly upregulated in neurons particularly in peri-infarct areas. The expression of CCR3 and CCR5, receptors for RANTES, was also induced in neurons, while another receptor, CCR1, was observed in vascular cells, in peri-infarct areas after MCAO. We examined the effects of RANTES on differentiated PC12 cells, a model of neuronal cells. Treatment with RANTES induced the activation of Akt and Erk1/2, and attenuated the cleavage of caspase-3 in the cells. RANTES increased the expression of BDNF, EGF, and VEGF in the cells. Moreover, RANTES maintained the number of cells under serum free conditions. The RANTES-mediated upregulation of neurotrophic factors and cell survival were significantly attenuated by the inhibition of Akt or Erk1/2. Taken together, RANTES is an interesting chemokine that is produced from neurons after ischemic stroke and has the potential to protect neurons directly or indirectly through the production of neurotrophic factors in peri-infarct areas.",
author = "Himiko Tokami and Tetsuro Ago and Hiroshi Sugimori and Junya Kuroda and Hideto Awano and Kazuo Suzuki and Yutaka Kiyohara and Masahiro Kamouchi and Takanari Kitazono",
year = "2013",
month = "6",
day = "23",
doi = "10.1016/j.brainres.2013.04.022",
language = "English",
volume = "1517",
pages = "122--132",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke

AU - Tokami, Himiko

AU - Ago, Tetsuro

AU - Sugimori, Hiroshi

AU - Kuroda, Junya

AU - Awano, Hideto

AU - Suzuki, Kazuo

AU - Kiyohara, Yutaka

AU - Kamouchi, Masahiro

AU - Kitazono, Takanari

PY - 2013/6/23

Y1 - 2013/6/23

N2 - Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) is a well-known pro-inflammatory chemokine and its role in ischemic stroke remains controversial. We examined the significance of RANTES in ischemic stroke and aimed to elucidate the direct effect of RANTES on neurons. Plasma concentrations of major C-C chemokines, including RANTES, and neurotrophic factors were examined in 171 ischemic stroke patients and age- and gender- matched healthy subjects. Plasma concentrations of RANTES at day 0 after onset were significantly elevated in stroke patients, compared with controls, and were highly correlated with those of BDNF, EGF, and VEGF. In a mouse middle cerebral artery occlusion model (MCAO), plasma RANTES was significantly elevated and the expression of RANTES was markedly upregulated in neurons particularly in peri-infarct areas. The expression of CCR3 and CCR5, receptors for RANTES, was also induced in neurons, while another receptor, CCR1, was observed in vascular cells, in peri-infarct areas after MCAO. We examined the effects of RANTES on differentiated PC12 cells, a model of neuronal cells. Treatment with RANTES induced the activation of Akt and Erk1/2, and attenuated the cleavage of caspase-3 in the cells. RANTES increased the expression of BDNF, EGF, and VEGF in the cells. Moreover, RANTES maintained the number of cells under serum free conditions. The RANTES-mediated upregulation of neurotrophic factors and cell survival were significantly attenuated by the inhibition of Akt or Erk1/2. Taken together, RANTES is an interesting chemokine that is produced from neurons after ischemic stroke and has the potential to protect neurons directly or indirectly through the production of neurotrophic factors in peri-infarct areas.

AB - Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) is a well-known pro-inflammatory chemokine and its role in ischemic stroke remains controversial. We examined the significance of RANTES in ischemic stroke and aimed to elucidate the direct effect of RANTES on neurons. Plasma concentrations of major C-C chemokines, including RANTES, and neurotrophic factors were examined in 171 ischemic stroke patients and age- and gender- matched healthy subjects. Plasma concentrations of RANTES at day 0 after onset were significantly elevated in stroke patients, compared with controls, and were highly correlated with those of BDNF, EGF, and VEGF. In a mouse middle cerebral artery occlusion model (MCAO), plasma RANTES was significantly elevated and the expression of RANTES was markedly upregulated in neurons particularly in peri-infarct areas. The expression of CCR3 and CCR5, receptors for RANTES, was also induced in neurons, while another receptor, CCR1, was observed in vascular cells, in peri-infarct areas after MCAO. We examined the effects of RANTES on differentiated PC12 cells, a model of neuronal cells. Treatment with RANTES induced the activation of Akt and Erk1/2, and attenuated the cleavage of caspase-3 in the cells. RANTES increased the expression of BDNF, EGF, and VEGF in the cells. Moreover, RANTES maintained the number of cells under serum free conditions. The RANTES-mediated upregulation of neurotrophic factors and cell survival were significantly attenuated by the inhibition of Akt or Erk1/2. Taken together, RANTES is an interesting chemokine that is produced from neurons after ischemic stroke and has the potential to protect neurons directly or indirectly through the production of neurotrophic factors in peri-infarct areas.

UR - http://www.scopus.com/inward/record.url?scp=84878491701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878491701&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2013.04.022

DO - 10.1016/j.brainres.2013.04.022

M3 - Article

C2 - 23602964

AN - SCOPUS:84878491701

VL - 1517

SP - 122

EP - 132

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -